glp-1 receptor agonist drug list Comparing Ozempic, Wegovy and Other Drugs Frontiers | GLP−1 receptor agonists
Description
Quesada BM, Kohan G, Roff HE, Canulln CM, Chiappetta Porras LT
Focusing on whole, unprocessed foods that contain complex carbohydrates can help maintain stable GLP-1 levels
The cohort comprised patients over 20 years old who were newly treated with glucose-lowering drugs between 1 January 2013 and 31 December 2021, and followed until 30 September 2022
Two other pharmaceutical companies have their own oral GLP-1 drugs in the works: Orforglipron: Developed by Eli Lilly, its in Phase 3 clinical trials for treating type 2 diabetes and obesity, with an expected September 2025 completion
Furthermore, AMPK inhibitor compound C abolished the metformin-mediated upregulation of GLP-1R level and PKA phosphorylation
